Proteomic variation in heart tissues
Induced pluripotent stem cells, or iPSCs, can be used to model tissues and disorders, such as heart diseases. However, the human heart is complex, with several regions and cell types. Therefore, analyzing single cardiac cells can be challenging.
Lizhuo Ai, Aleksandra Binek and Vladimir Zhemkov of the Cedars-Sinai Medical Center and a team in the U.S. used this approach to analyze heart cells throughout various stages of development. They published their in Molecular & Cellular Proteomics. The authors differentiated iPSCs into cardiomyocytes, the muscle cells of the heart, and analyzed their proteome at various time points using mass spectrometry.

The team detected proteomic differences between groups of iPSC-derived cardiomyocytes, or iCMs, at the end of their three-week differentiation period, suggesting that they had developed into multiple cell subtypes. Many differentially expressed proteins between two of these subtypes functioned in extracellular vesicles, called exosomes, which transport biomolecules such as DNA and proteins to other cells. They also compared iCMs to those isolated from adult human hearts, or aCMs. They found the two cell types shared many proteins involved in muscle function, but that aCMs had a higher proportion of mitochondrial proteins, suggesting that iCMs are metabolically immature.
Furthermore, detailed analysis revealed that a few human adult heart cells expressed markers that traditionally identify heart and brain cells, which may represent a newly discovered cell type. These results could mean that heart cells are more diverse than scientists originally thought and could underlie some functions such as exosome formation. The ability of iCMs to recreate much of the cardiomyocyte proteome, combined with the diversity of tissues they produce, make iPSCs appealing candidates for studying and treating human heart diseases.
Enjoy reading 91ӰToday?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from 91ӰToday
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

Receptor antagonist reduces age-related bone loss in mice
Receptor antagonist reduces bone loss and promotes osteoblast activity in aging mice, highlighting its potential to treat osteoporosis. Read more about this recent JBC paper.

Engineered fusion protein targets kiwifruit pathogen
Synthetic protein selectively kills kiwifruit pathogen, offering a promising biocontrol strategy for agriculture. Read more about this recent JBC paper.

Pathogen-derived enzyme engineered for antibiotic design
Engineered variants of a bacterial enzyme developed at the University at Buffalo accept larger substrates, paving the way for new acinetobactin-based antimicrobials. Read more about this recent JBC paper.

Omega-3 fats linked to healthy aging and improved heart metabolism
Scientists from the University of Iowa find that a diet high in polyunsaturated fatty acids from fish oil increases cardiac triglyceride uptake and improves insulin sensitivity. Read more about this recent JLR study.

RA patient blood reveals joint innerworkings
Researchers in the Netherlands use mass spectrometry to compare the proteome of plasma and synovial fluid in rheumatoid arthritis patients and find a correlation. Read more about this recent paper in Molecular & Cellular Proteomics.

Hope for a cure hangs on research
Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.